Differentiated thyroid cancer and outcome in iodine deficiency

European Journal of Surgical Oncology

Volumn 30, Issue 3, 2004, Pages 325-331

  Gyory, F ^a   Balazs, Gy ^a   Nagy, E V ^a   Juhasz, F ^a   Mezosi, E ^a   Szakall, Sz ^a   Math, J ^a   Lukacs, G ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Follicular cancer; Papillary cancer; Prognostic risk factors

Indexed keywords

IODINE;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUNGARY; IODINE DEFICIENCY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL RATE; THYROID CANCER; TUMOR DIFFERENTIATION;

EID: 1842435205     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2003.11.017     Document Type: Article

References (35)

1. Ain KB. Papillary thyroid carcinoma: Etiology, assessment, and therapy. Endocrinol Metab Clin North Am 1995;24(4): 711-760.
2. Fraker DL, Skarulis M, LiVolsi V. Thyroid tumors. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer-principles and practice of oncology. 5th ed. Philadelphia: Lippincott, 1997; p. 1629-51.
3. Mezosi E, Bajnok L, Gyory F, Varga J, Sztojka I, Szabo J, Galuska L, Leovey A, Kakuk Gy, Nagy E. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the differential diagnosis of cold thyroid nodules. Eur J Nucl-Med 1999;26:798-803.
4. Akslen LA, Myking AO, Salvesen H, Varhaug JE. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 1993; 29A:44-51.
5. Byar DP, Green SB, Dor P, Williams ED, Colon J, Van Gilse HA, Mayer M, Sylvester RJ, Van Glabbeke M. A prognostic index for thyroid carcinoma: A study of the EORTC. Thyroid Cancer Cooperative Group. Eur J Cancer 1979; 15:1033-1041.
6. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104: 947-953.
7. Hay ID, Bergstrahl EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114:1050-1058.
8. Hay ID, Grant CS, Taylor WF, McConahay WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987; 102:1088-1095.
9. Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanebe S, Uchino S, Toda M, Sasaki A, Daa T, Nakayama I. Chronic thyroiditis as a favourable prognostic factor in papillary thyroid carcinoma. Thyroid 1998;8:197-201.
10. Mezosi E, Molnar I, Jakab A, Balogh E, Karanyi Zs, Pakozdy Zs, Nagy P, Gyory F, Bajnok L, Leovey A, Kakuk Gy, Nagy EV. Prevalence of iodine deficiency and goitre during pregnancy in east Hungary. Eur J Endocrinol 2000; 143:479-483.
11. Mueller-Gaertner H-W, Brzac HT, Rehpenning W. Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 1991; 67:1903-1911.
12. Sanders LE, Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 1998; 133(4):419-425.
13. Sellers M, Beenken S, Blankenship A, Soong S, Turbat-Herrera E, Urist M, Maddox W. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg 1992; 164:578-581.
14. Shaha AR, Loree TR, Shah JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995;8:1131-1138.
15. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T. Papillary and follicular thyroid cancer: prognostic factors in 1578 patients. Am J Med 1987; 83:479-488.
16. Baloch ZW, LiVolsi VA. Prognostic factors in well-differentiated follicular derived carcinoma and medullary thyroid carcinoma. Thyroid 2001;11:637-645.
17. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA. Distant metastasis in differentiated thyroid carcinoma: A multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988;67:501-508.
18. Cady B. Predictors of thyroid tumor aggressiveness. In: Clark CH, Duh QY (eds) Endocrine surgery. Philadelphia: WB Saunders; 1997. p. 197-204.
19. Delange F. The disorders induced by iodine deficiency. Thyroid 1994;4:107-128.
20. Péter F. Status of iodine nutrition of Hungary. In: Delange F, Dunn JT, Glinoer D (eds) Iodine deficiency in Europe. New York: Plenum Press; 1993. p. 377-382.
21. Sajgo M, Farkas I. Iodine content of drinking water and indicators of iodine supply of Hungarian population (in Hungarian) Egészségtudomány 1990;34:28-33.
22. Noguchi S, Yamashita H, Murakami N, Nakayama I, Maasakatsu T, Kawamoto H. Small carcinomas of the thyroid. Arch Surg 1996; 131:187-191.
23. Schlumberger M, Pacini F. Prognostic factors. In: Schlumberger M, Pacini F (eds) Thyroid tumors. Paris: Nucléon; 1999. p. 85-131.
24. Kebebew E, Duh QY, Clark OH. Total thyroidectomy or total thyroid lobectomy in patients with low-risk differentiated cancer: surgical decision analysis of a controversy using mathematical model. World J Surg 2000; 24:1295-1302.
25. Machens A, Hinze R, Lautenschlager C, Thomusch O, Drall H. Prophylactic completion thyroidectomy for differentiated thyroid carcinoma: Prediction of extrathyroidal soft tissue infiltrates. Thyroid 2001; 11:381-384.
26. DeGroot LJ, Kaplan EL, Straus FH, Shukla MS. Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 1994; 18:123-130.
27. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-428.
28. Shah JP, Loree TR, Dharker D, Strong EW. Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: A matched-pair analysis. Am J Surg 1993;166: 331-335.
29. Clark OH. Papillary thyroid carcinoma: Rationale for total thyroidectomy. In: Clark CH, Duh QY (eds) Endocrine surgery. Philadelphia: WB Saunders; 1997. p. 90-93.
30. Fukunaga FH, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer 1975;36:1095-1099.
31. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 1999;84(2):458-463.
32. Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudoh K, Kuma K, Tamai H. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 1995;80:3421-3430.
33. Loh K-C, Greenspan FS, Gee L, Miller TR, Yea PPB. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 1999;84:458-463.
34. Gupta S, Patel A, Folstad A, Fenton C, Dinauer CA, Tuttle RM, Conran R, Francis GL. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J Clin Endocrinol Metab 2001;86:1346-1354.
35. Loh K-C, Greenspan FS, Gee L, Miller TR, Yeo PPB. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients. J Clin Endocrinol Metab 1997;82: 3553-3562.